The American Society of Hematology Conference is upon us again, with the HealthTree Team excited and ready to report the most interesting and important news released at this important meeting to our myeloma community.
Over the past month, team members have identified important abstracts that will presented by researchers and specialists at this conference regarding multiple myeloma, and we are committed to writing clear, understandable articles on these abstracts so that you can stay up to date with the latest myeloma research.
There is so much research being done in the myeloma field right now, and we're excited about it.
Stay tuned this week, month (and the following month) as we share our insights from important studies regarding topics such as:
- CAR-T Therapy and Bispecific Antibodies
- Extramedullary and High-Risk Myeloma Treatment
- Financial Toxicity for Myeloma Patients
- Minimal Residual Disease Testing
- Clinical Trial Participation
- Latest Myeloma Treatment/Drug Updates
and much, much more.
We look forward to communicating this important information with each of you. Keep an eye on our website and share the information you learn with your family and friends!
Would you like to watch the top interviews from ASH 2023? Click "ASH 2023" here: HealthTree University Conference Coverage
about the author
Audrey is the Editor for the HealthTree Foundation for Multiple Myeloma. She originally joined the HealthTree Foundation in 2020 as the Myeloma Community Program Director. While not knowing much about myeloma initially, she worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys iced chais from Dutch Bros. She also loves spending time with her supportive husband and energetic three-year-old.